<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01258231</url>
  </required_header>
  <id_info>
    <org_study_id>2000P001639</org_study_id>
    <secondary_id>5R01HL098601</secondary_id>
    <nct_id>NCT01258231</nct_id>
    <nct_alias>NCT00281164</nct_alias>
  </id_info>
  <brief_title>Identification of Genomic Predictors of Adverse Events After Cardiac Surgery</brief_title>
  <acronym>CABGGenomics</acronym>
  <official_title>Identification of Genomic Predictors of Adverse Events After Cardiac Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brigham and Women's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Heart, Lung, and Blood Institute (NHLBI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>Texas Heart Institute</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Texas Southwestern Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Brigham and Women's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to identify genetic causes of adverse events after cardiac surgery, such as&#xD;
      atrial fibrillation, myocardial infarction, renal dysfunction and heart failure.&#xD;
&#xD;
      Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute&#xD;
      are eligible to participate.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study aims to identify genetic causes of adverse events after cardiac surgery, such as&#xD;
      atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. In addition,&#xD;
      we also examine blood and urine biomarkers (proteins).&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>August 2000</start_date>
  <completion_date type="Anticipated">August 2030</completion_date>
  <primary_completion_date type="Anticipated">August 2030</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Mortality (i.e. number of participants who are deceased during postoperative day 0 up to year 5)</measure>
    <time_frame>Day of procedure to year 5</time_frame>
    <description>Data will be collected from electronic medical records; data points to be collected for this measurement include serum creatinine.</description>
  </primary_outcome>
  <other_outcome>
    <measure>Acute Kidney Injury using KDIGO criteria: albumin/creatinine ratio (&gt;/= 300 mg/g) and eGRF (&lt; 60 mL/min/1.73^2)</measure>
    <time_frame>Day of procedure to post procedure day 7</time_frame>
    <description>Data will be collected from electronic medical records; data points to be collected for this measurement include serum creatinine.</description>
  </other_outcome>
  <other_outcome>
    <measure>Presence of Arrhythmia (i.e. number of patients who develop an arrhythmia after their cardiac surgery)</measure>
    <time_frame>Day of procedure to year 5</time_frame>
    <description>Data will be collected from electronic medical records; data points to be collected for this measurement include post-procedural EKG reports and progress notes.</description>
  </other_outcome>
  <other_outcome>
    <measure>Myocardial Infarction (i.e. number of participants who develop a MI during postoperative day 0 to year 5)</measure>
    <time_frame>Day of procedure to year 5</time_frame>
    <description>Data will be collected from electronic medical records; data points to be collected for this measurement include post-procedural EKG reports, cardiac enzyme values, progress notes, and cardiac catheterization reports.</description>
  </other_outcome>
  <other_outcome>
    <measure>Heart failure per NYHA class II, III, IV</measure>
    <time_frame>Day of procedure to year 5</time_frame>
    <description>This will be measured in accordance to New York Heart Association Guidelines.</description>
  </other_outcome>
  <other_outcome>
    <measure>Quality of Life Survey - The Kansas City Cardiomyopathy Questionnaire (KCCQShortForm)</measure>
    <time_frame>Administered once prior to the procedure and 1 month to 5 years after hospital discharge</time_frame>
    <description>A questionnaire to assess for heart failure</description>
  </other_outcome>
  <other_outcome>
    <measure>Quality of Life Survey - The Seattle Angina Questionnaire (SAQShortForm)</measure>
    <time_frame>Administered once prior to the procedure and 1 month to 5 years after hospital discharge</time_frame>
    <description>A questionnaire to assess for angina</description>
  </other_outcome>
  <other_outcome>
    <measure>Quality of Life Survey - 12-item short form health survey (SF12)</measure>
    <time_frame>Administered once prior to the procedure and 1 month to 5 years after hospital discharge</time_frame>
    <description>A questionnaire to assess for overall health</description>
  </other_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">4000</enrollment>
  <condition>Heart; Dysfunction Postoperative, Cardiac Surgery</condition>
  <condition>Genetic Predisposition to Disease</condition>
  <condition>Atrial Fibrillation</condition>
  <condition>Myocardial Infarction</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Cardiac surgery</arm_group_label>
    <description>Adult patients undergoing cardiac surgery</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      DNA, buffy coat, plasma, serum and urine&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients undergoing heart surgery&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Undergoing heart surgery&#xD;
&#xD;
          -  Willing to provide consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Enrolled in a concurrent drug or device trial that precludes concurrent enrollment&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jochen D Muehlschlegel, MD MMSc, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brigham and Women's Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Brigham and Women's Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02115</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location>
    <facility>
      <name>UT Southwestern Medical Center</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75390-9068</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Amanda A Fox, MD</last_name>
      <phone>214-648-8018</phone>
      <email>amanda.fox@utsouthwestern.edu</email>
    </contact>
    <investigator>
      <last_name>Amanda A Fox, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Department Texas Heart Institute at St. Luke's Episcopal Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77225</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Completed</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Sigurdsson MI, Muehlschlegel JD, Fox AA, Heydarpour M, Lichtner P, Meitinger T, Collard CD, Shernan SK, Body SC. Genetic Variants Associated With Atrial Fibrillation and PR Interval Following Cardiac Surgery. J Cardiothorac Vasc Anesth. 2015;29(3):605-10. doi: 10.1053/j.jvca.2014.10.028. Epub 2014 Nov 4.</citation>
    <PMID>26009287</PMID>
  </reference>
  <reference>
    <citation>Barnet CS, Liu X, Body SC, Collard CD, Shernan SK, Muehlschlegel JD, Jarolim P, Fox AA. Plasma corin decreases after coronary artery bypass graft surgery and is associated with postoperative heart failure: a pilot study. J Cardiothorac Vasc Anesth. 2015 Apr;29(2):374-81. doi: 10.1053/j.jvca.2014.11.001. Epub 2014 Nov 11.</citation>
    <PMID>25649697</PMID>
  </reference>
  <reference>
    <citation>Fox AA, Pretorius M, Liu KY, Collard CD, Perry TE, Shernan SK, De Jager PL, Hafler DA, Herman DS, DePalma SR, Roden DM, Muehlschlegel JD, Donahue BS, Darbar D, Seidman JG, Body SC, Seidman CE. Genome-wide assessment for genetic variants associated with ventricular dysfunction after primary coronary artery bypass graft surgery. PLoS One. 2011;6(9):e24593. doi: 10.1371/journal.pone.0024593. Epub 2011 Sep 30.</citation>
    <PMID>21980348</PMID>
  </reference>
  <reference>
    <citation>Fox AA, Marcantonio ER, Collard CD, Thoma M, Perry TE, Shernan SK, Muehlschlegel JD, Body SC. Increased peak postoperative B-type natriuretic peptide predicts decreased longer-term physical function after primary coronary artery bypass graft surgery. Anesthesiology. 2011 Apr;114(4):807-16. doi: 10.1097/ALN.0b013e31820ef9c1.</citation>
    <PMID>21427536</PMID>
  </reference>
  <reference>
    <citation>Muehlschlegel JD, Liu KY, Perry TE, Fox AA, Collard CD, Shernan SK, Body SC; CABG Genomics Investigators. Chromosome 9p21 variant predicts mortality after coronary artery bypass graft surgery. Circulation. 2010 Sep 14;122(11 Suppl):S60-5. doi: 10.1161/CIRCULATIONAHA.109.924233.</citation>
    <PMID>20837927</PMID>
  </reference>
  <reference>
    <citation>Muehlschlegel JD, Perry TE, Liu KY, Fox AA, Collard CD, Shernan SK, Body SC. Heart-type fatty acid binding protein is an independent predictor of death and ventricular dysfunction after coronary artery bypass graft surgery. Anesth Analg. 2010 Nov;111(5):1101-9. doi: 10.1213/ANE.0b013e3181dd9516. Epub 2010 May 10.</citation>
    <PMID>20457766</PMID>
  </reference>
  <reference>
    <citation>Perry TE, Muehlschlegel JD, Liu KY, Fox AA, Collard CD, Shernan SK, Body SC; CABG Genomics Investigators. Plasma neutrophil gelatinase-associated lipocalin and acute postoperative kidney injury in adult cardiac surgical patients. Anesth Analg. 2010 Jun 1;110(6):1541-7. doi: 10.1213/ANE.0b013e3181da938e. Epub 2010 Apr 30.</citation>
    <PMID>20435938</PMID>
  </reference>
  <reference>
    <citation>Perry TE, Muehlschlegel JD, Liu KY, Fox AA, Collard CD, Body SC, Shernan SK; CABG Genomics Investigators. Preoperative C-reactive protein predicts long-term mortality and hospital length of stay after primary, nonemergent coronary artery bypass grafting. Anesthesiology. 2010 Mar;112(3):607-13. doi: 10.1097/ALN.0b013e3181cea3b5.</citation>
    <PMID>20179497</PMID>
  </reference>
  <reference>
    <citation>Garvin S, Muehlschlegel JD, Perry TE, Chen J, Liu KY, Fox AA, Collard CD, Aranki SF, Shernan SK, Body SC. Postoperative activity, but not preoperative activity, of antithrombin is associated with major adverse cardiac events after coronary artery bypass graft surgery. Anesth Analg. 2010 Oct;111(4):862-9. doi: 10.1213/ANE.0b013e3181b7908c. Epub 2009 Oct 9.</citation>
    <PMID>19820236</PMID>
  </reference>
  <reference>
    <citation>Perry TE, Muehlschlegel JD, Liu KY, Fox AA, Collard CD, Body SC, Shernan SK; CABG Genomics Investigators. C-Reactive protein gene variants are associated with postoperative C-reactive protein levels after coronary artery bypass surgery. BMC Med Genet. 2009 May 8;10:38. doi: 10.1186/1471-2350-10-38.</citation>
    <PMID>19426506</PMID>
  </reference>
  <reference>
    <citation>Muehlschlegel JD, Perry TE, Liu KY, Nascimben L, Fox AA, Collard CD, Avery EG, Aranki SF, D'Ambra MN, Shernan SK, Body SC; CABG Genomics Investigators. Troponin is superior to electrocardiogram and creatinine kinase MB for predicting clinically significant myocardial injury after coronary artery bypass grafting. Eur Heart J. 2009 Jul;30(13):1574-83. doi: 10.1093/eurheartj/ehp134. Epub 2009 Apr 30.</citation>
    <PMID>19406870</PMID>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>December 9, 2010</study_first_submitted>
  <study_first_submitted_qc>December 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 10, 2010</study_first_posted>
  <last_update_submitted>May 7, 2021</last_update_submitted>
  <last_update_submitted_qc>May 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brigham and Women's Hospital</investigator_affiliation>
    <investigator_full_name>Jochen Daniel Muehlschlegel, MD</investigator_full_name>
    <investigator_title>Associate Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atrial Fibrillation</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Disease Susceptibility</mesh_term>
    <mesh_term>Genetic Predisposition to Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

